These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6604003)

  • 21. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor.
    Nemerson Y; Repke D
    Thromb Res; 1985 Nov; 40(3):351-8. PubMed ID: 4082113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An assay for coagulation factor VII using factor VII-depleted bovine plasma.
    Nemerson Y; Clyne LP
    J Lab Clin Med; 1974 Feb; 83(2):301-3. PubMed ID: 4810955
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of methods for the measurement of activated factor VII.
    Kitchen S; Malia RG; Preston FE
    Thromb Haemost; 1992 Sep; 68(3):301-5. PubMed ID: 1440496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelations between the clotting and kinin systems. Activation of factor VII involving prekallikrein-kallikrein. A review.
    Stormorken H; Gjoennaess H; Laake K
    Haemostasis; 1973-1974; 2(6):245-52. PubMed ID: 4278152
    [No Abstract]   [Full Text] [Related]  

  • 25. Cold promoted activation of factor VII. I. Evidence for the existence of an activator.
    Gjonnaess H
    Thromb Diath Haemorrh; 1972 Oct; 28(2):155-68. PubMed ID: 4639650
    [No Abstract]   [Full Text] [Related]  

  • 26. Specific assays of hemostasis proteins: factor VII.
    Poggio M
    Ric Clin Lab; 1990; 20(2):139-41. PubMed ID: 2371493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma.
    Miller GJ; Seghatchian MJ; Walter SJ; Howarth DJ; Thompson SG; Esnouf MP; Meade TW
    Br J Haematol; 1986 Feb; 62(2):379-84. PubMed ID: 3484967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the cold activation of Factor VII and the prothrombin time.
    Palmer RN; Gralnick HR
    Am J Clin Pathol; 1984 May; 81(5):618-22. PubMed ID: 6202135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VII Padua 1. Another case.
    Croze M; Brizard CP
    Haemostasis; 1982; 11(3):185-8. PubMed ID: 7095606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inter-relationship of factor VII and its activity state with plasma lipids in healthy male adults.
    Wright D; Poller L; Thomson JM; Gowland E; Burrows GE
    Br J Haematol; 1993 Oct; 85(2):348-51. PubMed ID: 8280607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation factor VII. (Biochemistry, role in blood coagulation, methods of assay, congenital deficiencies and relationship with thrombosis).
    Mariani G; Mandelli F
    Ric Clin Lab; 1983; 13(3):287-98. PubMed ID: 6606207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface.
    Altman R; Rouvier J; Reussi C
    Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.
    Sidelmann JJ; Skouby SO; Kluft C; Winkler U; Vitzthum F; Schwarz H; Gram J; Jespersen J
    Thromb Res; 2011 Nov; 128(5):e67-72. PubMed ID: 21737124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of factor VII in the intrinsic pathway: a brief review.
    Prydz H
    Haemostasis; 1983; 13(3):156-60. PubMed ID: 6350120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
    Peverill RE; Teede HJ; Smolich JJ; Malan E; Kotsopoulos D; Tipping PG; McGrath BP
    Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation monitor based on serum migration through absorbent materials.
    Wilson PE
    Clin Chem; 1997 Sep; 43(9):1716-8. PubMed ID: 9299965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant treatment.
    Avvisati G; ten Cate JW; van Wijk EM; Kahlé LH; Mariani G
    Br J Haematol; 1980 Jun; 45(2):343-52. PubMed ID: 7437329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclical changes in coagulation factors associated with the use of progestational agents.
    McGrath KM; Castaldi PA
    Haemostasis; 1975; 4(2):73-80. PubMed ID: 1205338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple screening techniques for the detection of hypercoagulation. A study of 53 children suffering from familial hypercholesterolemia type IIa.
    Zondag AC; Kolb AM; Muller AD
    Haemostasis; 1984; 14(6):445-52. PubMed ID: 6335989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.